The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sukhija Remy since 2022.
This trader's CIK number is 1806949.
At the time of last reporting, Sukhija Remy was the Chief Commercial Officer of Madrigal Pharmaceuticals, Inc.. (stock ticker symbol MDGL).
Also see all insider trading activities at Madrigal Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | MDGL | 0 | $0 | 30,000 | $8,258,220 | 30,000 | $1,807,800 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-12-23 | MDGL | Sale | 30,000 | 275.27 | 8,258,220 |
| 2022-12-23 | MDGL | Option Ex | 30,000 | 60.26 | 1,807,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sukhija Remy (Chief Commercial Officer of Madrigal Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.